Earnings Per Share, Basic of CNBX Pharmaceuticals Inc. from 28 Feb 2021 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
CNBX Pharmaceuticals Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 28 Feb 2021 to 30 Nov 2025.
  • CNBX Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending 30 Nov 2025 was 0.
  • CNBX Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending 30 Nov 2025 was 0.
  • CNBX Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2025 was 0.
  • CNBX Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2024 was -0.02, a 95% increase from 2023.
  • CNBX Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -0.42, a 88% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

CNBX Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0 0 +0.001 01 Sep 2025 30 Nov 2025 10-Q 14 Jan 2026 2026 Q1
Q3 2025 0 0 0 01 Jun 2025 31 Aug 2025 10-K 01 Dec 2025 2025 FY
Q2 2025 0 0 0 01 Mar 2025 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 0 0 +0.01 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 -0.01 -0.001 +0.005 +83% 01 Sep 2024 30 Nov 2024 10-Q 14 Jan 2026 2026 Q1
Q3 2024 -0.02 0 -1.26 -100% 01 Jun 2024 31 Aug 2024 10-K 01 Dec 2025 2025 FY
Q2 2024 1.24 0 +0.02 01 Mar 2024 31 May 2024 10-Q 14 Jul 2025 2025 Q3
Q1 2024 1.22 -0.01 +1.32 +99% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q2
Q4 2023 -0.1 -0.006 +0.324 +98% 01 Sep 2023 30 Nov 2023 10-Q 13 Jan 2025 2025 Q1
Q3 2023 -0.42 1.26 +3.78 01 Jun 2023 31 Aug 2023 10-K 29 Nov 2024 2024 FY
Q2 2023 -4.2 -0.02 +0.03 +60% 01 Mar 2023 31 May 2023 10-Q 15 Jul 2024 2025 Q3
Q1 2023 -4.23 -1.33 -0.32 -32% 01 Dec 2022 28 Feb 2023 10-Q 16 Apr 2024 2024 Q2
Q4 2022 -3.91 -0.33 -0.32 -3200% 01 Sep 2022 30 Nov 2022 10-Q 12 Jan 2024 2024 Q1
Q3 2022 -3.59 -2.52 01 Jun 2022 31 Aug 2022 10-K 30 Nov 2023 2023 FY
Q2 2022 -0.05 +1.12 +96% 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2023 Q3
Q1 2022 -1.01 -1.01 -25350% 01 Dec 2021 28 Feb 2022 10-Q 14 Apr 2023 2023 Q2
Q4 2021 -0.01 01 Sep 2021 30 Nov 2021 10-Q 13 Jan 2023 2023 Q1
Q2 2021 -1.17 01 Mar 2021 31 May 2021 10-Q 14 Jul 2022 2022 Q3
Q1 2021 0.004 01 Dec 2020 28 Feb 2021 10-Q 12 Apr 2022 2022 Q2

CNBX Pharmaceuticals Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 0 +0.02 01 Sep 2024 31 Aug 2025 10-K 01 Dec 2025 2025 FY
2024 -0.02 +0.4 +95% 01 Sep 2023 31 Aug 2024 10-K 01 Dec 2025 2025 FY
2023 -0.42 +3.17 +88% 01 Sep 2022 31 Aug 2023 10-K 29 Nov 2024 2024 FY
2022 -3.59 -3.57 -17850% 01 Sep 2021 31 Aug 2022 10-K 30 Nov 2023 2023 FY
2021 -0.02 01 Sep 2020 31 Aug 2021 10-K 30 Nov 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.